{"id":10814,"date":"2025-02-28T11:20:06","date_gmt":"2025-02-28T10:20:06","guid":{"rendered":"https:\/\/orsingher.com\/stefano-giberti-su-il-sole-24-ore-tracciatura-europea-dei-medicinali-le-novita-italiane-e-il-rischio-della-bacchettata-ue\/"},"modified":"2025-03-04T11:24:33","modified_gmt":"2025-03-04T10:24:33","slug":"stefano-giberti-su-il-sole-24-ore-tracciatura-europea-dei-medicinali-le-novita-italiane-e-il-rischio-della-bacchettata-ue","status":"publish","type":"post","link":"https:\/\/orsingher.com\/en\/stefano-giberti-su-il-sole-24-ore-tracciatura-europea-dei-medicinali-le-novita-italiane-e-il-rischio-della-bacchettata-ue\/","title":{"rendered":"Stefano Giberti in Il Sole 24 Ore, &#8220;European Traceability of Medicines, the Italian novelties and the risk of an EU &#8220;stick&#8221;"},"content":{"rendered":"<p>In Il Sole 24 Ore, Stefano Giberti analyses Legislative Decree no. 10 of 6 February 2025 on the &#8220;European traceability&#8221; of the adaptation of national legislation to the European provisions on the safety features appearing on the packaging of medicines for human use.<\/p>\n<p>The instruments implemented by the legislator The &#8216;Made in Italy&#8217; requirement that &#8216;sends companies into crisis The risk of an infringement procedure.<\/p>\n<p>Full article in <a href=\"https:\/\/www.ilsole24ore.com\/art\/tracciatura-europea-medicinali-novita-italiane-e-rischio-bacchettata-ue-AGemvtBD\" target=\"_blank\" rel=\"noopener\">Il sole 24 Ore<\/a>.<\/p>\n<p>&nbsp;<\/p>\n<div style=\"width: 1080px;\" class=\"wp-video\"><video class=\"wp-video-shortcode\" id=\"video-10814-1\" width=\"1080\" height=\"1080\" preload=\"metadata\" controls=\"controls\"><source type=\"video\/mp4\" src=\"https:\/\/orsingher.com\/wp-content\/uploads\/2025\/03\/Sole24Ore_Life-Sciences.mp4?_=1\" \/><a href=\"https:\/\/orsingher.com\/wp-content\/uploads\/2025\/03\/Sole24Ore_Life-Sciences.mp4\">https:\/\/orsingher.com\/wp-content\/uploads\/2025\/03\/Sole24Ore_Life-Sciences.mp4<\/a><\/video><\/div>\n","protected":false},"excerpt":{"rendered":"<p>In Il Sole 24 Ore, Stefano Giberti analyses Legislative Decree no. 10 of 6 February 2025 on the &#8220;European traceability&#8221; of the adaptation of national legislation to the European provisions on the safety features appearing on the packaging of medicines for human use. The instruments implemented by the legislator The &#8216;Made in Italy&#8217; requirement that [&hellip;]<\/p>\n","protected":false},"author":6,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_members_access_role":[],"_members_access_error":""},"categories":[63,64],"tags":[],"class_list":["post-10814","post","type-post","status-publish","format-standard","hentry","category-news-en-2","category-press-en-2"],"acf":[],"_links":{"self":[{"href":"https:\/\/orsingher.com\/en\/wp-json\/wp\/v2\/posts\/10814","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/orsingher.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/orsingher.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/orsingher.com\/en\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/orsingher.com\/en\/wp-json\/wp\/v2\/comments?post=10814"}],"version-history":[{"count":0,"href":"https:\/\/orsingher.com\/en\/wp-json\/wp\/v2\/posts\/10814\/revisions"}],"wp:attachment":[{"href":"https:\/\/orsingher.com\/en\/wp-json\/wp\/v2\/media?parent=10814"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/orsingher.com\/en\/wp-json\/wp\/v2\/categories?post=10814"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/orsingher.com\/en\/wp-json\/wp\/v2\/tags?post=10814"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}